Emmanuel (ed) baetge, chief scientific officer at san Diego biotech Novocell, may be closer than anyone else to using embryonic stem cells to cure Type 1 diabetes. His work shows the immense promise of stem cell transplants-and the huge hurdles that stand in the way of their becoming a medical reality.
展开▼
